Reassessment of Premedication in Surgery
Overview
The purpose of this study is to test the level of anxiety in patients, the day before surgery (late afternoon) and immediately prior to surgery in 3 parallel groups of patients. – one receiving placebo before going to sleep (before sleep), the day prior surgery and placebo when awakening (awakening), the day of surgery – one receiving zopiclone (7.5 mg) before sleep and placebo at awakening – one receiving placebo before sleep and alprazolam (0.5 mg)at awakening double blind, randomized controlled study
Full Title of Study: “Assessment of Two Modes of Premedication in Surgery – PREMED Study”
Study Type
- Study Type: Interventional
- Study Design
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Primary Purpose: Treatment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Study Primary Completion Date: April 2013
Detailed Description
Eligibility: – 18 to 65 years old – elective surgery – in-hospital preoperative night Outcome measures: – anxiety scales – demographic data
Interventions
- Drug: Zopiclone
- 7.5 mg before sleep, the evening before surgery
- Drug: Alprazolam
- 0.5 mg at awakening, the day of surgery
- Drug: placebo
- given night before surgery and at awakening, the day of surgery
Arms, Groups and Cohorts
- Experimental: zopiclone
- zopiclone given before sleep, the day before surgery (placebo given at awakening the day of surgery)
- Experimental: alprazolam
- given at awakening, the day of surgery (placebo given before sleep, the day before surgery)
- Placebo Comparator: placebo
- Placebo given night before operation and the morning of operation
Clinical Trial Outcome Measures
Primary Measures
- anxiety scales
- Time Frame: duration of the study : 12 hours (one evaluation on late afternoon the day before surgery and the second evaluation on arrival to operating room)
- * The day before surgery (late afternoon) : patient’s self rating of anxiety and desire of information regarding upcoming surgery (Amsterdam patient anxiety and information scale, APAIS) * On arrival to the operating room : Recording of the level of declared anxiety (numeric scale similar to that corresponding of the “anxiety component of the APAIS scale)
Secondary Measures
- markers of stress
- Time Frame: on arrival to operating room (one single recording)
- recording of actual (using the operating room monitor): heart rate (at rest, supine) systolic blood pressure (at rest, supine)
Participating in This Clinical Trial
Inclusion Criteria
- age 18-65 years old – elective surgery – in-hospital night before surgery Exclusion Criteria:
- myasthenia gravis – chronic intake of psychotropic drugs – opiates intake – severe obstructive sleep apnea – intracranial hypertension – morbid obesity – myasthenia gravis – acute severe medical disorder – non health insurance coverage – protected patients by law – pregnancy – non French speaking
Gender Eligibility: All
Minimum Age: 18 Years
Maximum Age: 65 Years
Are Healthy Volunteers Accepted: No
Investigator Details
- Lead Sponsor
- University Hospital, Angers
- Provider of Information About this Clinical Study
- Sponsor
- Overall Official(s)
- Laurent Beydon, MD, Study Chair, University Hospital Angers (Dept of Anesthesia)
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.